Clinical trial

Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis

NCT01967134

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-11-01

PhasePHASE1

Study timeline

Study start (unknown)2011-11-01Date precision: month

Registry last updated2019-08-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Latent Tuberculosisunresolved

Latent Tuberculosis Bacteriology and Histology Unknownunresolved

Interventions

H56:IC31BIOLOGICAL

Sponsors & collaborators

Aeraslead sponsor

Statens Serum Institutcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01967134 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.